CBD vs THC

Anyone buying, selling or formulating needs all three straight, and all three start from the same question: does it get you high?

What is verified, and what is reported. Three things are verified: each compound's chemical identity, whether it intoxicates, and its legal framework. Each carries a grade or a dated legal snapshot. Anything about effects, benefits, or uses comes from third parties, such as manufacturers, the media or early research, and CBG Atlas does not make, adopt, or affirm those claims. Grade chips follow how we grade evidence, and gaps in the evidence are flagged where they occur. Not medical or legal advice. The full disclaimer closes the page.

At a glance

On a spec sheet the two best-known cannabinoids are hard to tell apart, C21H30O2 both. On a label, a lab report or a drug-test result they could hardly sit further apart, and every one of those differences traces back to intoxication.

What's actually established

Strip away the marketing and three facts are left standing: THC intoxicates and CBD doesn't, they share a molecular formula, and standard drug tests hunt for THC. Most of the wellness benefits sold on either compound are third-party claims that human research has yet to confirm.

• Intoxication is the dividing line. THC switches on the CB1 receptor as an agonist, and that activation is the mechanism of the cannabis "high" Established. CBD stays on the sober side of the line; it is non-intoxicating Established.
• One formula, two shapes. CBD and THC are both C21H30O2. The difference is architecture, with a closed ring in THC and an open form in CBD. That structural difference lines up with one compound intoxicating and the other staying sober, so a matching formula is a poor guide to effect. Established · chemical identity.
• Drug tests are built around THC. Standard screens detect THC and its metabolite THC-COOH Established, so using THC can produce a positive, while CBD falls outside what they look for. The catch sits in the bottle. Many CBD products, full-spectrum ones in particular, can contain trace THC, and that trace can sometimes lead to a positive, so the outcome is a matter of odds either way. A batch's certificate of analysis (COA) lists its THC content. (Product-THC caveat: attributed, hedged.)
• Legal status tracks intoxication, place by place. Under the 2018 Farm Bill, US hemp-derived CBD with no more than 0.3% Δ9-THC by dry weight is broadly legal federally. Above that threshold THC remains a federally controlled Schedule I substance, even as many states separately allow medical or adult-use cannabis. The map differs by jurisdiction and gets redrawn over time. [Legal snapshot — dated/jurisdictional; not legal advice].
• Approved medicines are a regulatory fact with limits. A prescription medicine for certain rare seizure disorders uses CBD as its active ingredient, and some jurisdictions have approved specific prescription cannabinoid medicines. Each is a distinct, regulated product, and each approval stops at its own label: over-the-counter consumer claims sit outside it, and a consumer brand has no way to borrow it. Established · regulatory fact.
• THC impairs. Driving, coordination and judgment can all suffer under THC; while impaired, do not drive or operate machinery. Established.
• Most benefit claims, for either compound, lack human evidence. The "entourage effect", the idea that the compounds act together when combined, is hypothesised and marketed, and rigorous human trials have not established it. Low · / Hypothesized · catalogue in progress.

Common questions

Informational only — not our claims, and not advice

The statements on this page about potential effects, benefits, or uses reflect claims made by third parties (manufacturers, media, traditional use, or preliminary research) and are presented for educational and informational purposes only. CBG Atlas does not make, adopt, endorse, or affirm these claims, and does not represent them as fact. These statements have not been evaluated by the Food and Drug Administration (or any regulator) and are not intended to diagnose, treat, cure, or prevent any disease. Nothing here is medical, legal, or professional advice; cannabinoid effects, safety, and legal status vary by person, product, and jurisdiction and can change over time. Consult a qualified professional before making any health or purchasing decision. Where we can, we show how strong the evidence is and cite the source; where evidence is thin or absent, we say so. Peregrine Biopharma funds the platform and holds no editorial authority.

Report a safety event: if you experienced a possible adverse effect from a cannabinoid product, please report it via the platform's "Report a safety event" path.

Verified identity facts: CBD (C21H30O2 · CAS 13956-29-1 · non-intoxicating) and THC (C21H30O2 · CAS 1972-08-3 · intoxicating) are structural isomers. Intoxication status and the drug-test target (THC / THC-COOH) are graded established. Effect, benefit and "entourage" statements are attributed to third parties or marked catalogue in progress. Legal statements are dated, jurisdictional and not legal advice.